US Stock MarketDetailed Quotes

Grace Therapeutics (GRCE)

Watchlist
  • 2.300
  • -0.050-2.13%
Close Apr 24 16:00 ET
  • 2.290
  • -0.010-0.43%
Post 20:01 ET
35.59MMarket Cap-7.42P/E (TTM)

Grace Therapeutics (GRCE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
45.81%-2.23M
25.86%-3.14M
49.92%-1.8M
-20.85%-14.9M
-41.48%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.50%-12.33M
37.22%-2.09M
Net income from continuing operations
44.31%-2.31M
72.64%-939K
-28.47%-3.36M
25.56%-9.57M
120.09%636K
-73.78%-4.16M
-4.86%-3.43M
34.95%-2.62M
69.71%-12.85M
89.12%-3.17M
Operating gains losses
-96.60%40K
-295.29%-1.43M
134.91%487K
-218.76%-3.22M
-355.37%-2.64M
1,034.92%1.18M
---361K
---1.4M
7,864.71%2.71M
1,334.72%1.03M
Depreciation and amortization
50.00%3K
--0
100.00%2K
-36.36%7K
100.00%2K
100.00%2K
0.00%2K
-85.71%1K
-91.13%11K
-87.50%1K
Deferred tax
--0
--0
--0
-74.62%-3.2M
-14.51%-1.02M
-190.87%-605K
-91.03%-852K
-150.52%-724K
80.80%-1.83M
89.98%-889K
Other non cash items
----
----
----
----
----
----
----
--1K
----
----
Change In working capital
90.36%-67K
-586.63%-983K
-14.54%770K
126.72%342K
-109.38%-66K
-237.35%-695K
143.53%202K
144.47%901K
-807.18%-1.28M
99.43%704K
-Change in receivables
--0
--0
-67.48%106K
645.00%596K
-26.16%175K
193.44%114K
---19K
1,031.43%326K
126.49%80K
797.06%237K
-Change in prepaid assets
2.83%-103K
-42.07%84K
86.14%-47K
-153.97%-170K
-75.38%130K
-145.49%-106K
74.70%145K
35.92%-339K
337.50%315K
16.30%528K
-Change in payables and accrued expense
105.12%36K
-1,503.95%-1.07M
-22.21%711K
94.92%-84K
-508.20%-371K
-277.97%-703K
114.15%76K
163.08%914K
-501.95%-1.65M
8.96%-61K
-Change in other current assets
----
----
----
--0
--0
--0
--0
--0
---23K
--0
Cash from discontinued investing activities
Operating cash flow
45.81%-2.23M
25.86%-3.14M
49.92%-1.8M
-20.85%-14.9M
-41.48%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.50%-12.33M
37.22%-2.09M
Investing cash flow
Cash flow from continuing investing activities
0
0
0
0
0
100.23%15K
0
-15K
-99.21%104K
31.17%6.55M
Net PPE purchase and sale
----
----
----
--0
--0
--0
----
----
623.53%89K
-162.50%-21K
Net investment purchase and sale
--0
--0
--0
--0
--0
100.23%15K
--0
---15K
-99.89%15K
31.38%6.57M
Cash from discontinued investing activities
Investing cash flow
--0
--0
--0
--0
--0
100.23%15K
--0
---15K
-99.21%104K
31.17%6.55M
Financing cash flow
Cash flow from continuing financing activities
4.04M
0
-327K
90.68%14.03M
14.03M
0
0
0
2,320.72%7.36M
0
Net common stock issuance
----
----
----
99.99%15M
9,158.64%15M
--0
----
----
2,367.11%7.5M
--162K
Proceeds from stock option exercised by employees
----
----
----
--0
--0
--0
----
----
--21K
--0
Net other financing activities
--0
--0
---327K
-496.91%-967K
----
----
----
----
---162K
----
Cash from discontinued financing activities
Financing cash flow
--4.04M
--0
---327K
90.68%14.03M
--14.03M
--0
--0
--0
2,320.72%7.36M
--0
Net cash flow
Beginning cash position
11.26%16.86M
3.15%20.01M
-3.79%22.13M
-17.47%23.01M
-40.39%11.06M
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-8.12%27.88M
-29.33%18.55M
Current changes in cash
144.15%1.81M
25.86%-3.14M
41.07%-2.13M
82.09%-872K
148.39%11.08M
51.46%-4.1M
-179.14%-4.24M
42.13%-3.61M
-98.29%-4.87M
167.71%4.46M
Effect of exchange rate changes
----
----
----
----
----
----
----
--0
--0
----
End cash Position
68.90%18.67M
11.26%16.86M
3.15%20.01M
-3.79%22.13M
-3.79%22.13M
-40.39%11.06M
-43.85%15.16M
-10.35%19.39M
-17.47%23.01M
-17.47%23.01M
Free cash flow
45.81%-2.23M
25.86%-3.14M
49.92%-1.8M
-20.63%-14.9M
-40.00%-2.95M
-117.49%-4.12M
-100.62%-4.24M
42.37%-3.6M
22.44%-12.36M
36.71%-2.11M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 45.81%-2.23M25.86%-3.14M49.92%-1.8M-20.85%-14.9M-41.48%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.50%-12.33M37.22%-2.09M
Net income from continuing operations 44.31%-2.31M72.64%-939K-28.47%-3.36M25.56%-9.57M120.09%636K-73.78%-4.16M-4.86%-3.43M34.95%-2.62M69.71%-12.85M89.12%-3.17M
Operating gains losses -96.60%40K-295.29%-1.43M134.91%487K-218.76%-3.22M-355.37%-2.64M1,034.92%1.18M---361K---1.4M7,864.71%2.71M1,334.72%1.03M
Depreciation and amortization 50.00%3K--0100.00%2K-36.36%7K100.00%2K100.00%2K0.00%2K-85.71%1K-91.13%11K-87.50%1K
Deferred tax --0--0--0-74.62%-3.2M-14.51%-1.02M-190.87%-605K-91.03%-852K-150.52%-724K80.80%-1.83M89.98%-889K
Other non cash items ------------------------------1K--------
Change In working capital 90.36%-67K-586.63%-983K-14.54%770K126.72%342K-109.38%-66K-237.35%-695K143.53%202K144.47%901K-807.18%-1.28M99.43%704K
-Change in receivables --0--0-67.48%106K645.00%596K-26.16%175K193.44%114K---19K1,031.43%326K126.49%80K797.06%237K
-Change in prepaid assets 2.83%-103K-42.07%84K86.14%-47K-153.97%-170K-75.38%130K-145.49%-106K74.70%145K35.92%-339K337.50%315K16.30%528K
-Change in payables and accrued expense 105.12%36K-1,503.95%-1.07M-22.21%711K94.92%-84K-508.20%-371K-277.97%-703K114.15%76K163.08%914K-501.95%-1.65M8.96%-61K
-Change in other current assets --------------0--0--0--0--0---23K--0
Cash from discontinued investing activities
Operating cash flow 45.81%-2.23M25.86%-3.14M49.92%-1.8M-20.85%-14.9M-41.48%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.50%-12.33M37.22%-2.09M
Investing cash flow
Cash flow from continuing investing activities 00000100.23%15K0-15K-99.21%104K31.17%6.55M
Net PPE purchase and sale --------------0--0--0--------623.53%89K-162.50%-21K
Net investment purchase and sale --0--0--0--0--0100.23%15K--0---15K-99.89%15K31.38%6.57M
Cash from discontinued investing activities
Investing cash flow --0--0--0--0--0100.23%15K--0---15K-99.21%104K31.17%6.55M
Financing cash flow
Cash flow from continuing financing activities 4.04M0-327K90.68%14.03M14.03M0002,320.72%7.36M0
Net common stock issuance ------------99.99%15M9,158.64%15M--0--------2,367.11%7.5M--162K
Proceeds from stock option exercised by employees --------------0--0--0----------21K--0
Net other financing activities --0--0---327K-496.91%-967K-------------------162K----
Cash from discontinued financing activities
Financing cash flow --4.04M--0---327K90.68%14.03M--14.03M--0--0--02,320.72%7.36M--0
Net cash flow
Beginning cash position 11.26%16.86M3.15%20.01M-3.79%22.13M-17.47%23.01M-40.39%11.06M-43.85%15.16M-10.35%19.39M-17.47%23.01M-8.12%27.88M-29.33%18.55M
Current changes in cash 144.15%1.81M25.86%-3.14M41.07%-2.13M82.09%-872K148.39%11.08M51.46%-4.1M-179.14%-4.24M42.13%-3.61M-98.29%-4.87M167.71%4.46M
Effect of exchange rate changes ------------------------------0--0----
End cash Position 68.90%18.67M11.26%16.86M3.15%20.01M-3.79%22.13M-3.79%22.13M-40.39%11.06M-43.85%15.16M-10.35%19.39M-17.47%23.01M-17.47%23.01M
Free cash flow 45.81%-2.23M25.86%-3.14M49.92%-1.8M-20.63%-14.9M-40.00%-2.95M-117.49%-4.12M-100.62%-4.24M42.37%-3.6M22.44%-12.36M36.71%-2.11M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More